---
document_datetime: 2023-09-21 18:06:39
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/ambirix-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: ambirix-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.2091183
conversion_datetime: 2025-12-21 23:18:37.61785
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORIZATION

For procedures finalised after 01/04/2004 please refer to module 8B.

| Scope                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Change(s) to the test method(s) and/or specifications for the active substance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | II/0001              | II                       | 19/12/2002                          | 09/01/2003                               |
| Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | II/0002              | II                       | 18/12/2002                          | 09/01/2003                               |
| Change(s) to shelf-life or storage conditions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | II/0003              | II                       | 19/12/2002                          | 09/01/2003                               |
| Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | II/0004              | II                       | 20/02/2003                          | 06/03/2003                               |
| Change(s) to the test method(s) and/or specifications for the finished product                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | II/0005              | II                       | 25/09/2003                          | 02/10/2003                               |
| Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | II/0006              | II                       | 22/10/2003                          | 30/10/2003                               |
| Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | II/0007              | II                       | 22/10/2003                          | 30/10/2003                               |
| Amendment of sections 4.1, 4.2, 4.5, 4.8, 5.1 of the Summary of Product Characteristics (SPC) to extend the indication to include also children aged 1 to 5 years. As a consequence of the age extension, the MAH applied to include information on the concomitant administration of Ambirix with DTPa- IPV/Hib or MMR vaccines at separate injection sites in the second year of life.The Package Leaflet (PL) and labelling have been amended accordingly. In addition, the contacts of the German, Spanish, Irish, Portuguese and Finnish local representatives have been amended. | II/0010              | II                       | 21/01/04                            | 31/03/04                                 |
| Change in or addition of manufacturing site(s) for part or all of the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | I/0009               | I                        | 18/07/2003                          | -                                        |
| Change of the vaccine manufacturing facilities (filling and packaging) from \"GlaxoSmithkline Biologicals Manufacturing SA\" (GSK Bio Manufacturing) to \"GlaxoSmithkline Biologicals SA\" (GSK Bio).                                                                                                                                                                                                                                                                                                                                                                                      | IA/0011              | IA                       | 12/03/2004                          | -                                        |

1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.